Literature DB >> 9043967

Waist circumference reduction and cardiovascular benefits during weight loss in women.

T S Han1, P Richmond, A Avenell, M E Lean.   

Abstract

OBJECTIVE: To examine the relationship between waist circumference and cardiovascular risk factors during weight loss, and to consider possible waist reduction targets for weight management.
DESIGN: Single strand six month weight loss study on food based diets in 110 women aged 18-68 y, and body mass index > or = 25 kg/m2 set at an outpatient clinic. MAIN OUTCOME MEASURES: Waist circumference, weight, body mass index (BMI), total plasma cholesterol, low (LDL) and high density lipoprotein (HDL) cholesterol, triglyceride, and blood pressure.
RESULTS: Anthropometric and metabolic measurements improved with mean weight loss of 4.9 (s.e.m. +/- 0.4) kg at three months and 6.2 (s.e.m. +/- 0.4) kg at six months. Weight loss closely related to waist reduction (% Weight loss = 0.85 x Waist reduction (cm)-2.09; r = 0.79). The proportion of subjects with waist circumference below Action Level 1 (< 80 cm) or above Action Level 2 (> or = 88 cm) were 9 and 60% at baseline, 29 and 38% at three months and 36 and 33% at six months. Waist reduction (adjusted for age, smoking, alcohol consumption, diet treatment and baseline dependent and independent variables) correlated significantly with falls in total cholesterol (r = 0.31; P < 0.01), LDL cholesterol (r = 0.35; P < 0.01) and diastolic blood pressure (r = 0.32; P < 0.01), but not significantly with HDL cholesterol, triglyceride or systolic blood pressure. BMI showed similar correlations, whereas waist to hip ratio changes were not associated with changes in any cardiovascular risk factors. Amongst those whose waist fell by > or = 5 cm, 45 at three months and 43 at six months, there were > or = 10% improvements in at least one risk factor for 71 and 84% respectively. Amongst those whose waist fell by 5-10 cm, 40 women at three months and 30 at six months, at least one risk factor improved by > or = 10% in 70% and in 83% respectively.
CONCLUSIONS: Waist reduction of 5-10 cm in Caucasian women, across a range of baseline BMI 25-50 kg/m2 or waist circumference 72-133 cm, may be used as guideline to encourage overweight women to achieve a realistic target with a high probability of health benefits.

Entities:  

Mesh:

Year:  1997        PMID: 9043967     DOI: 10.1038/sj.ijo.0800377

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  31 in total

Review 1.  Reduced or modified dietary fat for preventing cardiovascular disease.

Authors:  Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen J Moore; George Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Evaluation of the Counterweight Programme for obesity management in primary care: a starting point for continuous improvement.

Authors: 
Journal:  Br J Gen Pract       Date:  2008-08       Impact factor: 5.386

3.  Indexes of abdominal adiposity in patients with type 2 diabetes.

Authors:  E Mannucci; S Spila Alegiani; M Monami; E Sarli; A Avogaro
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

4.  Assessment of equivalence of adipose tissue treatment with a noncontact field RF system delivering 200 W for 30 min and 300 W for 20 min: An in vivo porcine study.

Authors:  Tae-Rin Kwon; Jong Hwan Kim; Seok Joon; Seok Kyun Mun; Chan Woong Kim; Beom Joon Kim
Journal:  Laser Ther       Date:  2017-03-31

5.  Socioeconomic deprivation and waist circumference in men and women: The Scottish MONICA surveys 1989--1995.

Authors:  Ruoling Chen; Hugh Tunstall-Pedoe
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

6.  The combination of extracorporeal shock wave therapy and noncontact apoptosis-inducing radiofrequency achieved significant waist circumferential reduction: a pilot study.

Authors:  Hyeyeon Kim
Journal:  Laser Ther       Date:  2017-06-30

Review 7.  Waist circumference threshold values for type 2 diabetes risk.

Authors:  Karl E Friedl
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

Review 8.  Orlistat: a review of its use in the management of obesity.

Authors:  K M Hvizdos; A Markham
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

9.  Comparison of anthropometric parameters as predictors of serum lipids in premenopausal women.

Authors:  M N Moreira-Andrés; F J del Cañizo-Gómez; M A Losa; P Ferrando; A Gómez de la Cámara; F G Hawkins
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

10.  Change in waist circumference over 11 years and current waist circumference independently predict elevated CRP in Filipino women.

Authors:  Julienne N Rutherford; Thomas W McDade; Nanette R Lee; Linda S Adair; Christopherw Kuzawa
Journal:  Am J Hum Biol       Date:  2010 May-Jun       Impact factor: 1.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.